威高血净：拟购买威高普瑞100%股权 股票10月20日起停牌
Shandong Weigao Blood Purification ProductsShandong Weigao Blood Purification Products(SH:603014) Zheng Quan Shi Bao Wang·2025-10-17 11:41

Core Viewpoint - Weigao Blood Products (603014) is planning to acquire 100% equity of Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. through a share issuance, which is expected to constitute a major asset restructuring and related party transaction, but will not lead to a change in the actual controller of the company [1] Group 1 - The transaction is currently in the planning stage and carries uncertainties [1] - The company's stock will be suspended from trading starting October 20, 2025, with an expected suspension period of no more than 10 trading days [1]